INMODE LTD IS -01 - Asset Resilience Ratio
INMODE LTD IS -01 (154) has an Asset Resilience Ratio of 19.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read INMODE LTD IS -01 (154) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how INMODE LTD IS -01's Asset Resilience Ratio has changed over time. See INMODE LTD IS -01 shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down INMODE LTD IS -01's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 154 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €142.86 Million | 19.03% |
| Total Liquid Assets | €142.86 Million | 19.03% |
Asset Resilience Insights
- Good Liquidity Position: INMODE LTD IS -01 maintains a healthy 19.03% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
INMODE LTD IS -01 Industry Peers by Asset Resilience Ratio
Compare INMODE LTD IS -01's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760 |
Medical Devices | 0.64% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 50.79% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 6.89% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 33.68% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
LENSAR Inc
NASDAQ:LNSR |
Medical Devices | 13.15% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
Annual Asset Resilience Ratio for INMODE LTD IS -01 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for INMODE LTD IS -01.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 32.98% | €252.79 Million ≈ $295.54 Million |
€766.43 Million ≈ $896.04 Million |
-23.17pp |
| 2024-12-31 | 56.15% | €441.14 Million ≈ $515.74 Million |
€785.67 Million ≈ $918.53 Million |
-13.03pp |
| 2023-12-31 | 69.18% | €597.19 Million ≈ $698.18 Million |
€863.29 Million ≈ $1.01 Billion |
-0.63pp |
| 2022-12-31 | 69.81% | €449.84 Million ≈ $525.91 Million |
€644.41 Million ≈ $753.38 Million |
-- |
About INMODE LTD IS -01
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous ski… Read more